Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study

Alveolar soft part sarcoma (ASPS), epithelioid sarcoma (ES), and clear cell sarcoma (CCS) are known to be chemoresistant tumors. The aim of this study was to investigate the effect of pazopanib on these chemoresistant tumors. This study is designed as a single‐arm, multicenter, investigator‐initiate...

Descripción completa

Detalles Bibliográficos
Autores principales: Urakawa, Hiroshi, Kawai, Akira, Goto, Takahiro, Hiraga, Hiroaki, Ozaki, Toshifumi, Tsuchiya, Hiroyuki, Nakayama, Robert, Naka, Norifumi, Matsumoto, Yoshihiro, Kobayashi, Eisuke, Okuma, Tomotake, Kunisada, Toshiyuki, Ando, Masahiko, Ueda, Takafumi, Nishida, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469808/
https://www.ncbi.nlm.nih.gov/pubmed/32579783
http://dx.doi.org/10.1111/cas.14542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469808/
https://www.ncbi.nlm.nih.gov/pubmed/32579783
http://dx.doi.org/10.1111/cas.14542

Ejemplares similares